Mounjaro for type 2 diabetes is covered by more plans than ever. See if yours qualifies

Get started on Mounjaro, if prescribed
with tirzepatide · for type 2 diabetes
The FDA-approved once-weekly dual GIP/GLP-1 injection for type 2 diabetes, with meaningful A1c control and weight change. We check your insurance first, so you know what is covered before you pay.
Mounjaro is tirzepatide, a once-weekly injection FDA-approved to improve blood sugar in adults with type 2 diabetes, alongside diet and exercise.
What’s similar
What’s different
Program fees are paid to Body Good; your Mounjaro is billed through your insurance. With coverage, it can cost as little as $25/month with the Lilly Mounjaro savings card, if you are eligible.
Prescription only. Your clinician determines the medicine and the dose after reviewing your health history — you state a preference, and the clinician may prescribe something different, or nothing at all.
Safety info: GLP-1 medicines carry a Boxed Warning for the risk of thyroid C-cell tumors and are contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. This page is not medical advice. See more serious warnings & safety info
Real science, real results
≈2%

average A1c reduction*
In the SURPASS studies, adults with type 2 diabetes on tirzepatide saw average A1c reductions of roughly 1.9 to 2.6 percentage points, with weight reductions up to about 13% at the highest dose.*
Meet
Why patients choose it
Two hormones for glucose control
FDA approved
FDA approved for glycemic control in adults with type 2 diabetes.
Proven A1c control
Average A1c dropped roughly 2 points in studies, with significant weight change.*

Covered by many plans
We check your commercial or Medicare benefits first, so you know your cost before you commit.

100% online. Zero waiting rooms.
From the first visit to insurance support, we help you get — and stay — on track.
Start in 3 simple steps
No surprises, ever
One clear path: we use your insurance first, and you always see the price before you decide anything.
With coverage, your Mounjaro can cost as little as $25 / month with the Lilly Mounjaro savings card, if you are eligible.
Insurance concierge
One-time insurance processing fee
$95
charged once, today — the only charge today
Choose your starting dose
You select your starting dose upfront; your clinician confirms it and your titration. Your $95 insurance processing fee is charged once, today; your $75/mo program then starts one month later — the medication is billed through your insurance.
Your $95 insurance processing fee includes
Choose your ongoing plan
Selected: Monthly — $75 /mo · starts one month after enrollment, then every month
Your ongoing plan includes
Medication cost depends on your plan and dose. Savings-offer eligibility applies (commercial insurance only; not valid with government insurance such as Medicare or Medicaid).
Prefer we handle the whole insurance process?
Our GLP-1 Coverage Concierge does the eligibility check, prior authorization, appeals, and refills for you — start to finish.
Women on Mounjaro
Paid testimonials. Results have not been independently verified. Individual results will vary.


Dr. Linda Moleon — founder, Obesity Medicine Specialist. The same clinicians build your plan, file your prior authorization, and follow you refill after refill, in English and Spanish.
Meet the care team
Mounjaro is tirzepatide, a once-weekly injection FDA-approved to improve blood sugar in adults with type 2 diabetes, alongside diet and exercise.
Both are tirzepatide. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is the same molecule approved for chronic weight management.
Many commercial and Medicare plans cover Mounjaro for type 2 diabetes. Our free coverage check confirms your benefits before you pay anything.
Mounjaro is approved for type 2 diabetes; weight change is a studied effect, not its approved indication. For weight management, ask about Zepbound.
Most common are nausea, diarrhea, decreased appetite, vomiting, and constipation. Mounjaro carries a Boxed Warning about thyroid C-cell tumors. See full safety information below.
Start with a free insurance check. Real care is a few minutes away.
Check my coverageWhat you should know before taking Mounjaro.
Boxed Warning: Risk of thyroid C-cell tumors. In animal studies, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid carcinoma (MTC), in people. Do not use if you or any family member have ever had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are allergic to tirzepatide.
Mounjaro (tirzepatide) is a prescription medicine used with diet and exercise to improve blood sugar in adults with type 2 diabetes. It is not for type 1 diabetes. It may cause serious side effects, including inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar, kidney problems, and serious allergic reactions. The most common side effects are gastrointestinal — nausea, diarrhea, vomiting, and constipation. Tell your clinician about all your medical conditions and medications.
This page is for informational purposes and is not medical advice. Talk to a licensed clinician about whether this treatment is right for you. For full prescribing information and the Medication Guide, see the manufacturer's official materials.